NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 28 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,023 | -2.5% | 412,743 | 0.0% | 0.00% | – |
| Q2 2023 | $37,972 | +512.6% | 412,743 | +1631.1% | 0.00% | – |
| Q1 2023 | $6,199 | -38.1% | 23,843 | -50.0% | 0.00% | – |
| Q4 2022 | $10,014 | +66.9% | 47,686 | +100.0% | 0.00% | – |
| Q3 2022 | $6,000 | -64.7% | 23,843 | 0.0% | 0.00% | – |
| Q2 2022 | $17,000 | -10.5% | 23,843 | 0.0% | 0.00% | – |
| Q1 2022 | $19,000 | -20.8% | 23,843 | 0.0% | 0.00% | – |
| Q4 2021 | $24,000 | -42.9% | 23,843 | 0.0% | 0.00% | – |
| Q3 2021 | $42,000 | -4.5% | 23,843 | 0.0% | 0.00% | – |
| Q2 2021 | $44,000 | – | 23,843 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Allred Capital Management, LLC | 65,303 | $176,000 | 0.11% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 132,540 | $358,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 51,648 | $139,000 | 0.00% |
| PATHSTONE FAMILY OFFICE, LLC | 10,050 | $28,000 | 0.00% |
| LifePlan Financial Group, Inc | 1,440 | $4,000 | 0.00% |
| Sowell Financial Services LLC | 11,234 | $30,000 | 0.00% |
| Jacobi Capital Management LLC | 1,000 | $3,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 65,089 | $176,000 | 0.00% |
| Sound Income Strategies, LLC | 599 | $2,000 | 0.00% |
| UBS Group AG | 1,785 | $5,000 | 0.00% |